ODDO BHF Asset Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
ODDO BHF Asset Management's INZY Position: Q3 2025 in Review
ODDO BHF Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 3,200,000 shares — an estimated $12.8M sold.
ODDO BHF Asset Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $12.8M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.
- ODDO BHF Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
- ODDO BHF Asset Management sold 3,200,000 Inozyme Pharma shares in Q3 2025, an estimated $12.8M.
- ODDO BHF Asset Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
- ODDO BHF Asset Management's Inozyme Pharma position peaked at $12.8M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.
Based on ODDO BHF Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.